The autoantigen DNA topoisomerase i interacts with chemokine receptor 7 and exerts cytokine-like effects on dermal fibroblasts

Arthritis and Rheumatism

Volumn 64, Issue 3, 2012, Pages 826-834

  Arcand, Julie ^a   Robitaille, Geneviève ^a   Koenig, Martial ^a   Senécal, Jean Luc ^a   Raymond, Yves ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; DNA TOPOISOMERASE; FLUOROCHROME; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE C GAMMA1; PHYCOERYTHRIN; RAF PROTEIN; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ANTIGEN BINDING; ARTICLE; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; FLUOROCHROME STAINING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SKIN FIBROBLAST;

AUTOANTIBODIES; AUTOANTIGENS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL21; DERMIS; DNA TOPOISOMERASES, TYPE I; FIBROBLASTS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTORS, CCR7; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION;

EID: 84857753899     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.33377     Document Type: Article

References (40)

1. Nihtyanova SI, Denton CP,. Autoantibodies as predictive tools in systemic sclerosis. Nat Rev Rheumatol 2010; 6: 112-6.
2. Henault J, Tremblay M, Clement I, Raymond Y, Senecal JL,. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Arthritis Rheum 2004; 50: 3265-74.
3. Henault J, Robitaille G, Senecal JL, Raymond Y,. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients. Arthritis Rheum 2006; 54: 963-73.
4. Howard OM, Dong HF, Yang D, Raben N, Nagaraju K, Rosen A, et al. Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 2002; 196: 781-91.
5. Yang H, Wang H, Czura CJ, Tracey KJ,. The cytokine activity of HMGB1. J Leukoc Biol 2005; 78: 1-8.
6. Mitola S, Belleri M, Urbinati C, Coltrini D, Sparatore B, Pedrazzi M, et al. Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol 2006; 176: 12-5.
7. Howard OM, Dong HF, Su SB, Caspi RR, Chen X, Plotz P, et al. Autoantigens signal through chemokine receptors: uveitis antigens induce CXCR3- and CXCR5-expressing lymphocytes and immature dendritic cells to migrate. Blood 2005; 105: 4207-14.
8. Oppenheim JJ, Dong HF, Plotz P, Caspi RR, Dykstra M, Pierce S, et al. Autoantigens act as tissue-specific chemoattractants. J Leukoc Biol 2005; 77: 854-61.
9. Robitaille G, Henault J, Christin MS, Senecal JL, Raymond Y,. The nuclear autoantigen CENP-B displays cytokine-like activities toward vascular smooth muscle cells. Arthritis Rheum 2007; 56: 3814-26.
10. Howard OZ,. Autoantigen signalling through chemokine receptors. Curr Opin Rheumatol 2006; 18: 642-6.
11. Robitaille G, Christin MS, Clement I, Senecal JL, Raymond Y,. Nuclear autoantigen CENP-B transactivation of the epidermal growth factor receptor via chemokine receptor 3 in vascular smooth muscle cells. Arthritis Rheum 2009; 60: 2805-16.
12. Forster R, Davalos-Misslitz AC, Rot A,. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008; 8: 362-71.
13. Sanchez-Sanchez N, Riol-Blanco L, Rodriguez-Fernandez JL,. The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J Immunol 2006; 176: 5153-9.
14. Banas B, Wornle M, Berger T, Nelson PJ, Cohen CD, Kretzler M, et al. Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis. J Immunol 2002; 168: 4301-7.
15. Sakai N, Wada T, Yokoyama H, Lipp M, Ueha S, Matsushima K, et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A 2006; 103: 14098-103.
16. Bruhl H, Mack M, Niedermeier M, Lochbaum D, Scholmerich J, Straub RH,. Functional expression of the chemokine receptor CCR7 on fibroblast-like synoviocytes. Rheumatology (Oxford) 2008; 47: 1771-4.
17. Pierce EM, Carpenter K, Jakubzick C, Kunkel SL, Evanoff H, Flaherty KR, et al. Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21. Eur Respir J 2007; 29: 1082-93.
18. Kohout TA, Nicholas SL, Perry SJ, Reinhart G, Junger S, Struthers RS,. Differential desensitization, receptor phosphorylation, β-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. J Biol Chem 2004; 279: 23214-22.
19. Otero C, Groettrup M, Legler DF,. Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradation. J Immunol 2006; 177: 2314-23.
20. Bonacchi A, Petrai I, Defranco RM, Lazzeri E, Annunziato F, Efsen E, et al. The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology 2003; 125: 1060-76.
21. Pierce EM, Carpenter K, Jakubzick C, Kunkel SL, Flaherty KR, Martinez FJ, et al. Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice. Am J Pathol 2007; 170: 1152-64.
22. Singer AJ, Clark RA,. Cutaneous wound healing. N Engl J Med 1999; 341: 738-46.
23. Li W, Fan J, Chen M, Guan S, Sawcer D, Bokoch GM, et al. Mechanism of human dermal fibroblast migration driven by type I collagen and platelet-derived growth factor-BB. Mol Biol Cell 2004; 15: 294-309.
24. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH,. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β. J Exp Med 1987; 165: 251-6.
25. Postlethwaite AE, Keski-Oja J, Balian G, Kang AH,. Induction of fibroblast chemotaxis by fibronectin: localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment. J Exp Med 1981; 153: 494-9.
26. Seppa H, Grotendorst G, Seppa S, Schiffmann E, Martin GR,. Platelet-derived growth factor in chemotactic for fibroblasts. J Cell Biol 1982; 92: 584-8.
27. Huang C, Jacobson K, Schaller MD,. MAP kinases and cell migration. J Cell Sci 2004; 117: 4619-28.
28. Pullikuth AK, Catling AD,. Scaffold mediated regulation of MAPK signaling and cytoskeletal dynamics: a perspective. Cell Signal 2007; 19: 1621-32.
29. Diaz B, Barnard D, Filson A, MacDonald S, King A, Marshall M,. Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling. Mol Cell Biol 1997; 17: 4509-16.
30. Tvorogov D, Wang XJ, Zent R, Carpenter G,. Integrin-dependent PLC-γ1 phosphorylation mediates fibronectin-dependent adhesion. J Cell Sci 2005; 118: 601-10.
31. Buckley CT, Sekiya F, Kim YJ, Rhee SG, Caldwell KK,. Identification of phospholipase C-γ1 as a mitogen-activated protein kinase substrate. J Biol Chem 2004; 279: 41807-14.
32. Redondo-Munoz J, Jose Terol M, Garcia-Marco JA, Garcia-Pardo A,. Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration. Blood 2008; 111: 383-6.
33. Huang CY, Lee CY, Chen MY, Yang WH, Chen YH, Chang CH, et al. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-κB-dependent pathways. J Cell Physiol 2009; 221: 204-12.
34. Fields TA, Casey PJ,. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem J 1997; 321: 561-71.
35. Bardi G, Lipp M, Baggiolini M, Loetscher P,. The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC. Eur J Immunol 2001; 31: 3291-7.
36. Otero C, Eisele PS, Schaeuble K, Groettrup M, Legler DF,. Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis. J Cell Sci 2008; 121: 2759-67.
37. Mashino K, Sadanaga N, Yamaguchi H, Tanaka F, Ohta M, Shibuta K, et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 2002; 62: 2937-41.
38. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT,. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci U S A 1998; 95: 258-63.
39. Shannon LA, Calloway PA, Welch TP, Vines CM,. CCR7/CCL21 migration on fibronectin is mediated by phospholipase Cγ1 and ERK1/2 in primary T lymphocytes. J Biol Chem 2010; 285: 38781-7.
40. Tveita AA,. The danger model in deciphering autoimmunity. Rheumatology (Oxford) 2010; 49: 632-9.